SecBot SecBot
SECBOTREPLAY Home › Report › MDLN

MDLN · Medline reported Q2 2026 adjusted EPS of $0.50, beating consensus of…

Medline Inc. · PRESS-RELEASE filed Aug 5, 2026 at 07:30 ET

At the news

MIXEDIMPACT 6/10

PRESS-RELEASE filed Aug 5, 2026 at 07:30 ET

Medline reported Q2 2026 adjusted EPS of $0.50, beating consensus of $0.32 by 56%, and revenue of $7.69B, beating $7.51B by 2.3%. Organic sales guidance was raised to 9.0%-10.0% from 8.5%-9.5%, but Adjusted EBITDA guidance was cut to $3.3-$3.4B from $3.5-$3.6B, reflecting inflationary pressure, operational investments, and a $336M fire loss at the Tracy distribution center. The mixed guidance and one-time fire loss temper the strong headline beat.

  • Q2 2026 adjusted EPS of $0.50 beat consensus of $0.32 by 56%.
  • Q2 2026 net sales of $7.7B increased 11.6% YoY, beating consensus of $7.51B.
  • Organic sales guidance raised to 9.0%-10.0% from 8.5%-9.5%.
  • Adjusted EBITDA guidance cut to $3.3-$3.4B from $3.5-$3.6B.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access